Compare · DHR vs ESAB
DHR vs ESAB
Side-by-side comparison of Danaher Corporation (DHR) and ESAB Corporation (ESAB): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and ESAB operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $134.62B, about 26.2x ESAB ($5.14B).
- Over the past year, DHR is down 5.7% and ESAB is down 35.9% - DHR leads by 30.2 points.
- DHR has been more active in the news (6 items in the past 4 weeks vs 4 for ESAB).
- DHR has more recent analyst coverage (25 ratings vs 21 for ESAB).
- Company
- Danaher Corporation
- ESAB Corporation
- Price
- $191.49-0.47%
- $84.49+1.04%
- Market cap
- $134.62B
- $5.14B
- 1M return
- +1.42%
- -12.84%
- 1Y return
- -5.66%
- -35.88%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2022
- News (4w)
- 6
- 4
- Recent ratings
- 25
- 21
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
ESAB Corporation
ESAB Corporation formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. Its comprehensive range of welding consumables includes electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, including electrodes, nozzles, shields, and tips. The company's fabrication technology equipment ranges from portable welding machines to large customized automated cutting and welding systems. It also offers a range of digital software and solutions to help its customers increase their productivity, remotely monitor their welding operations, and digitize their documentation. The company sells its products under the ESAB brand to various end markets, including general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences. It offers its products through independent distributors and direct salespeople. ESAB Corporation was incorporated in 2021 and is based in Wilmington, Delaware.
Latest DHR
- Danaher Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Danaher Reports Second Quarter 2026 Results
- VP, Chief Accounting Officer Bouda Christopher covered exercise/tax liability with 60 shares, decreasing direct ownership by 0.65% to 9,107 units (SEC Form 4)
- Director Filler Linda exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 9% to 26,829 units (SEC Form 4)
- Director Zerhouni Elias A. exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 5% to 45,303 units (SEC Form 4)
- Audax Private Equity and Linden Capital Partners Agree to Sell StatLab Medical Products to Leica Biosystems
- Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa
- Danaher Schedules Second Quarter 2026 Earnings Conference Call
- Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
- SEC Form 11-K filed by Danaher Corporation
Latest ESAB
- SEC Form 4 filed by EVP, Business Operations Bhagwakar Ranjana N
- ESAB Corporation Schedules Second Quarter 2026 Earnings Release and Conference Call
- SEC Form 4 filed by EVP, Business Operations Bhagwakar Ranjana N
- SEC Form 3 filed by new insider Bhagwakar Ranjana N
- Executive Chair of Board Rales Mitchell P was granted 596 shares, increasing direct ownership by 4% to 16,432 units (SEC Form 4)
- SEC Form 4 filed by Director Teirlinck Didier P
- SEC Form 4 filed by Director Lutz Robert S
- SEC Form 424B7 filed by ESAB Corporation
- DA Davidson initiated coverage on ESAB Corp. with a new price target
- SEC Form 4 filed by Executive Chair of Board Rales Mitchell P